secwatch.observer — SEC 8-K summary
======================================

Issuer:     Valion Bio, Inc. (VBIO)
CIK:        0001787740
Form:       8-K
Filed at:   2025-03-06T23:59:59+00:00
Accession:  0000950170-25-034191
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tivic Health presents data showing personalized VNS nearly doubles HRV in 60% of participants
--------------------------------------------------------------------------------

- Data from Feinstein Institute collaboration presented at Sixth Bioelectronic Medicine Summit.
- Personalized ncVNS frequency optimized HRV change; no single frequency universally dominant.
- 60% of participants (responders) saw raw HRV nearly double on average post-stimulation.
- Normalized HRV increased 2.67x, indicating enhanced vagal tone and improved autonomic balance.
- Company believes findings support non-invasive devices for inflammatory, cardiac, neurologic disorders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787740/000095017025034191/0000950170-25-034191-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787740/000095017025034191/tivc-20250306.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-034191

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer